Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Alumis Inc.
Sponsor

Alumis Inc.

United States 280 East Grand Avenue, 94080-4808, United States

About the sponsor

Alumis Inc. focuses on clinical research in systemic lupus erythematosus, with interest in disease activity, immune-mediated inflammation, and clinical outcomes assessed through BILAG-based measures.

  • Systemic lupus erythematosus
  • Autoimmune disease activity
  • Inflammatory disease control

The sponsor’s lupus research is centered on therapeutic approaches aimed at reducing active disease burden and improving patient response in a chronic rheumatologic condition.

About Specializations

Alumis Inc. runs clinical trials in conditions such as Psoriasis, Systemic lupus erythematosus, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

4 clinical trials

Psoriasis

Not recruiting
Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Envudeucitinib
  • Sponsor:Alumis Inc.

Psoriasis

Not recruiting
Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Apremilast
  • Sponsor:Alumis Inc.

Psoriasis

Not recruiting
Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Apremilast
  • Sponsor:Alumis Inc.

Systemic lupus erythematosus

Not recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Esk-001
  • Sponsor:Alumis Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.